accountFrom Bloomberg News | Abbott Laboratories? Humira spurred resistance in more than a quarter of patients taking the rheumatoid arthritis drug in a study, a finding that may weaken demand for the company?s top-selling medicine. Related...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott's Humira tarnished by patient resistance
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account